Glenn J. Smits - Concepedia

Author

Glenn J. Smits

Biogen (United States)

Also Known As

G J Smits, G. J. Smits, G. Smits, G.J. Smits, Glenn J Smits, Glenn J. Smits, Glenn Smits, Smits, G.

Publications

860

Citations

H-Index

Concepts

All Affiliations

Biogen (United States)South College University of Missouri–St. Louis Medical College of Wisconsin Medical University of South Carolina

About

Glenn J. Smits is an author at Biogen (United States) specializing in medicine, pharmacology, and molecular pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	11	275
2	Natural Sciences	2	2	101
3	Education	1	1	32
4	Health Sciences	1	1	32
5	Applied Physiology	1	1	32

Glenn J. Smits

Publications

834

Citations

H-Index

Page 1

	Year	Citations
Evaluation of laser-Doppler flowmetry as a measure of tissue blood flow Glenn J. Smits, Richard J. Roman, Julian H. Lombard Journal of Applied Physiology	1986	216
Cardioprotective Effects of the Novel Adenosine A1/A2 Receptor Agonist AMP 579 in a Porcine Model of Myocardial Infarction Glenn J. Smits, Mathew McVey, B. F. Cox, Journal of Pharmacology and Experimental Therapeutics	1998	85
Novel Diamino Derivatives of [1,2,4]Triazolo[1,5-a][1,3,5]triazine as Potent and Selective Adenosine A<sub>2a</sub>Receptor Antagonists Chi B. Vu, Deborah Pan, Bo Peng, Journal of Medicinal Chemistry Molecular PharmacologyMedicinal ChemistryDerivativesBiochemistryFunctional Selectivity	2004	59
Thiorphan, an Inhibitor of Endopeptidase 24.11, Potentiates the Natriuretic Activity of Atrial Natriuretic Peptide Angelo J. Trapani, Glenn J. Smits, Dean E. McGraw, Journal of Cardiovascular Pharmacology NeuropeptidesRenal FunctionCardiovascular DiseaseNatriuretic ActivityMedicine	1989	49
Piperazine Derivatives of [1,2,4]Triazolo[1,5-<i>a</i>][1,3,5]triazine as Potent and Selective Adenosine A<sub>2</sub><sub>a</sub>Receptor Antagonists Chi B. Vu, Bo Peng, G. Kumaravel, Journal of Medicinal Chemistry	2004	44
Potent and Orally Bioavailable 8-Bicyclo[2.2.2]octylxanthines as Adenosine A<sub>1</sub> Receptor Antagonists William F. Kiesman, Jin Zhao, Patrick R. Conlon, Journal of Medicinal Chemistry Acid 29Molecular PharmacologyMedicinal ChemistryBiochemistryFunctional Selectivity	2006	42
Comparison of Three Different A1 Adenosine Receptor Antagonists on Infarct Size and Multiple Cycle Ischemic Preconditioning in Anesthetized Dogs John A. Auchampach, Xiaowei Jin, Jeannine Moore, Journal of Pharmacology and Experimental Therapeutics	2004	37
Cardiovascular Pharmacology of the Adenosine A1/A2-Receptor Agonist AMP 579: Coronary Hemodynamic and Cardioprotective Effects in the Canine Myocardium Matthew J. McVey, Glenn J. Smits, Bryan F. Cox, Journal of Cardiovascular Pharmacology	1999	34
Effect of head-out water immersion on response to exercise training Lois M. Sheldahl, Felix E. Tristani, Philip S. Clifford, Journal of Applied Physiology Physical ActivityAerobic ExerciseEducationCardiovascular FunctionKinesiology	1986	32
Cardiovascular and Antilipolytic Effects of the Adenosine Agonist GR79236 Linda Merkel, Eric D. Hawkins, Dennis Colussi, Pharmacology	1995	30

Page 1